BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

466 related articles for article (PubMed ID: 12672030)

  • 1. Tenascin-C upregulates matrix metalloproteinase-9 in breast cancer cells: direct and synergistic effects with transforming growth factor beta1.
    Kalembeyi I; Inada H; Nishiura R; Imanaka-Yoshida K; Sakakura T; Yoshida T
    Int J Cancer; 2003 May; 105(1):53-60. PubMed ID: 12672030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Co-stimulation of human breast cancer cells with transforming growth factor-beta and tenascin-C enhances matrix metalloproteinase-9 expression and cancer cell invasion.
    Ilunga K; Nishiura R; Inada H; El-Karef A; Imanaka-Yoshida K; Sakakura T; Yoshida T
    Int J Exp Pathol; 2004 Dec; 85(6):373-9. PubMed ID: 15566434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Interactions of ovarian carcinoma cells and human peritoneal mesothelial cells involved in matrix metalloproteinases expressions of ovarian carcinoma cells].
    Zhang JJ; Wang B
    Zhonghua Fu Chan Ke Za Zhi; 2006 Mar; 41(3):194-7. PubMed ID: 16640888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of matrix metalloproteinases in cyclosporin-treated gingival fibroblasts is regulated by transforming growth factor (TGF)-beta1 autocrine stimulation.
    Cotrim P; de Andrade CR; Martelli-Junior H; Graner E; Sauk JJ; Coletta RD
    J Periodontol; 2002 Nov; 73(11):1313-22. PubMed ID: 12479636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zerumbone suppresses the motility and tumorigenecity of triple negative breast cancer cells via the inhibition of TGF-β1 signaling pathway.
    Kim S; Lee J; Jeon M; Lee JE; Nam SJ
    Oncotarget; 2016 Jan; 7(2):1544-58. PubMed ID: 26637807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of tenascin expression in cultured rat dental pulp cells.
    Horibe M; Sawa T; Kataoka M; Kido J; Nagata T
    Odontology; 2004 Sep; 92(1):22-6. PubMed ID: 15490301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of transforming growth factor β1 on the expression of matrix metalloproteinase 9, tissue inhibitor of metalloproteinase 1 and nuclear factor kappa B signalling pathway in the human amniotic cells WISH].
    Fan MS; Jiang ZY; Zou YF; Qu L; Zhou X; Sun LZ
    Zhonghua Fu Chan Ke Za Zhi; 2013 Jan; 48(1):29-33. PubMed ID: 23531248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of platelet-derived growth factor and transforming growth factor beta1 the in the regulation of metalloproteinase expressions.
    Borrelli V; di Marzo L; Sapienza P; Colasanti M; Moroni E; Cavallaro A
    Surgery; 2006 Sep; 140(3):454-63. PubMed ID: 16934609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Transforming growth factor-beta1 stimulates matrix metalloproteinase-9 production through ERK activation pathway and upregulation of Ets-1 protein].
    Huang HC; Liu SY; Liang Y; Liu Y; Li JZ; Wang HY
    Zhonghua Yi Xue Za Zhi; 2005 Feb; 85(5):328-31. PubMed ID: 15854510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Notch pathway mediates the angiotensin II-induced synthesis of extracellular matrix components in podocytes.
    Yao M; Wang X; Wang X; Zhang T; Chi Y; Gao F
    Int J Mol Med; 2015 Jul; 36(1):294-300. PubMed ID: 25902289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of matrix metalloproteinase-2 and -9 and their inhibitors, tissue inhibitor of metalloproteinase-1 and -2, in primary cultures of human prostatic stromal and epithelial cells.
    Wilson MJ; Sellers RG; Wiehr C; Melamud O; Pei D; Peehl DM
    J Cell Physiol; 2002 May; 191(2):208-16. PubMed ID: 12064464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of matrix metalloproteinase-3 in mouse endometrial stromal cells during early pregnancy: regulation by interleukin-1alpha and tenascin-C.
    Nishiura R; Noda N; Minoura H; Toyoda N; Imanaka-Yoshida K; Sakakura T; Yoshida T
    Gynecol Endocrinol; 2005 Aug; 21(2):111-8. PubMed ID: 16109598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extracellular matrix is modulated in advanced glycation end products milieu via a RAGE receptor dependent pathway boosted by transforming growth factor-β1 RAGE.
    Serban AI; Stanca L; Geicu OI; Munteanu MC; Costache M; Dinischiotu A
    J Diabetes; 2015 Jan; 7(1):114-24. PubMed ID: 24666836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced tenascin-C expression and matrix deposition during Ras/TGF-beta-induced progression of mammary tumor cells.
    Maschler S; Grunert S; Danielopol A; Beug H; Wirl G
    Oncogene; 2004 Apr; 23(20):3622-33. PubMed ID: 15116096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone morphogenetic protein (BMP)-4 and BMP-7 regulate differentially transforming growth factor (TGF)-beta1 in normal human lung fibroblasts (NHLF).
    Pegorier S; Campbell GA; Kay AB; Lloyd CM
    Respir Res; 2010 Jun; 11(1):85. PubMed ID: 20573231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osteoblast-derived TGF-beta1 modulates matrix degrading protease expression and activity in prostate cancer cells.
    Festuccia C; Angelucci A; Gravina GL; Villanova I; Teti A; Albini A; Bologna M
    Int J Cancer; 2000 Feb; 85(3):407-15. PubMed ID: 10652434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transforming growth factor-beta 1 promotes matrix metalloproteinase-9-mediated oral cancer invasion through snail expression.
    Sun L; Diamond ME; Ottaviano AJ; Joseph MJ; Ananthanarayan V; Munshi HG
    Mol Cancer Res; 2008 Jan; 6(1):10-20. PubMed ID: 18234959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TGF-beta1 stimulates production of gelatinase (MMP-9), collagenases (MMP-1, -13) and stromelysins (MMP-3, -10, -11) by human corneal epithelial cells.
    Kim HS; Shang T; Chen Z; Pflugfelder SC; Li DQ
    Exp Eye Res; 2004 Aug; 79(2):263-74. PubMed ID: 15325573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced invasiveness of breast cancer cell lines upon co-cultivation with macrophages is due to TNF-alpha dependent up-regulation of matrix metalloproteases.
    Hagemann T; Robinson SC; Schulz M; Trümper L; Balkwill FR; Binder C
    Carcinogenesis; 2004 Aug; 25(8):1543-9. PubMed ID: 15044327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High glucose decreases matrix metalloproteinase-2 activity in rat mesangial cells via transforming growth factor-beta1.
    Singh R; Song RH; Alavi N; Pegoraro AA; Singh AK; Leehey DJ
    Exp Nephrol; 2001; 9(4):249-57. PubMed ID: 11423724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.